Risk assessment of venous thromboembolism in medical patients

Baglin, 1997, Fatal pulmonary embolism in hospitalised medical patients, J Clin Pathol, 50, 609, 10.1136/jcp.50.7.609 Baron, 1998, Venous thrombosis and cancer, Lancet, 351, 1077, 10.1016/S0140-6736(97)10018-6 Bergmann, 1996, A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness, Thromb Haemost, 76, 529, 10.1055/s-0038-1650617 Harenberg, 1996, Subcutaneous low molecular weight heparin versus standard heparin and the prevention of thromboembolism in medical patients, Haemostasis, 26, 127 Hillborn, 1998, Enoxaparin, a low molecular weight heparin, is superior to heparin in the prevention of deep vein thrombosis in stroke patients, Ann Hematol, 76, V15 Kleber, 1998, Study to compare the efficacy and safety of the LMWH enoxaparin and standard heparin in the prevention of thromboembolic events in medical patients with cardiopulmonary diseases, Ann Hematol, 76, P261 Lechler, 1996, The venous thrombotic risk in non-surgical patients: Epidemiological data and efficacy/safety profile of a low molecular weight heparin (enoxaparin), Haemostasis, 26, 49 Levine, 1988, The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer, N Engl J Med, 318, 404, 10.1056/NEJM198802183180703 Samama, 1999, A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients, N Engl J Med, 341, 793, 10.1056/NEJM199909093411103 Schulman, 1998, Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group, Am J Med, 104, 332, 10.1016/S0002-9343(98)00060-6 Sørensen, 1998, The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism, N Engl J Med, 338, 1169, 10.1056/NEJM199804233381701 1992, Risk of and prophylaxis for venous thromboembolism in hospital patients, BMJ, 304, 567